2024 HCPCS Code M0249
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
TAGS: invasive patients supplemental receiving intravenous corticosteroids infusion administration pediatric oxygenation years extracorporeal mechanical require hospitalized systemic first membrane
Short Description | Adm tocilizu covid-19 1st |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | June 24, 2021 |
HCPCS Code Added Date | June 24, 2021 |
HCPCS Pricing Indicator Code | 54 - Vaccinations |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- M1320 - Pts scrn + hrsn
- M1321 - Pts no 7wk inj,no iop,iop>25
- M1322 - Pts 7wk inj, scrn iop =<25
- M1323 - Pts 7wk inj, scrn iop >25
- M1324 - Pts intravitreal/pci
- M1325 - Doc med rsn not seen
- M1326 - Pts dx hypotony
- M1327 - Pts no eval ini xm no 8 wks
- M1328 - Pts dx acute vitreous hem
- M1329 - Pts act pvd 2 wks 8 wks
- M1330 - Doc pts rsn no f/u xm
- M1331 - Pts eval ini xm 8 wks
- M1332 - Pts no eval ini xm no 2 wks
- M1333 - Acute vitreous hemorrhage
- M1334 - Pts act pvd 2 wks 2 wks
- M1335 - Doc pts rsn no f/u xm
- M1336 - Pts eval ini xm 2 wks
- M1337 - Acute pvd
- M1338 - Pt f/u 30-180 dys no + imprv
- M1339 - Pts f/u 30-180 dys + improv